
iSpecimen Investor Relations Material
Latest events

Q2 2024
iSpecimen

Q1 2025
18 May, 2025

Q4 2024
14 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from iSpecimen Inc
Access all reports
iSpecimen Inc. is a technology-driven company that connects researchers with human biospecimens for medical research and development. Through its proprietary online marketplace, the company facilitates the procurement of biological samples, including blood, tissue, and other biofluids, from a global network of healthcare providers. iSpecimen serves pharmaceutical companies, biotechnology firms, academic institutions, and government organizations involved in drug discovery, diagnostics, and precision medicine. iSpecimen Inc. is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for iSpecimen Inc


Q2 2024
iSpecimen Inc


Q2 2024
iSpecimen Inc
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
ISPC
Country
🇺🇸 United States